Shots: GI to receive up front, milestones, and royalties on sales in China, including mainland China, Hong Kong, Macau, and Taiwan while Simcere will be responsible for all clinical development, […]readmore
Tags : Licensing
Shots: Takeda enters into a licensing agreement with Curadev for its Stimulator of Interferon Genes (STING) agonist/ CRD5500 and its associated patents The focus of the agreement is to develop […]readmore
Shots: Avidity to receive $20M upfront, $15M equity investment, $405M as development, regulatory & commercial milestones for each target and royalties on sales. Lilly to get WW rights to develop […]readmore
Shots: Codexis to receive $3M milestone and NHSc to get exclusive WW rights to develop and commercialize Codexis’s CDX-6114 for phenylketonuria (PKU) In 2017, Codexis & NHSc collaborated to develop […]readmore
Shots: Enterome to get $50M upfront plus $640M as milestones payments and future equity investment commitment from Takeda. The companies will jointly co-develop EB8018 and if approved, the product will […]readmore